Author:
Atya Hanaa B.,Ali Sahar A.,Hegazy Mohamed I.,El Sharkawi Fathia Z.
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol. 2005;23:683–747.
2. Miller E, Walczak A, Saluk J, Ponczek MB, Majsterek I. Oxidative modification of patient’s plasma proteins and its role in pathogenesis of multiple sclerosis. Clin Biochem. 2012;45(1–2):26–30. doi: 10.1016/j.clinbiochem.2011.09.021 .
3. Tremlett H, van der Mei IA, Pittas F, Blizzard L, Paley G, Mesaros D, et al. Monthly ambient sunlight, infections and relapse rates in multiple sclerosis. Neuroepidemiology. 2008;31(4):271–9. doi: 10.1159/000166602 .
4. Marrie RA, Cohen JA. Interferons in secondary progressive multiple sclerosis, in multiple sclerosis therapeutics. 3rd ed. London: Informa Healthcare; 2007.
5. Gebregiworgis T, Massilamany C, Gangaplara A, Thulasingam S, Kolli V, Werth MT, et al. The potential of urinary metabolites for diagnosing multiple sclerosis. ACS Chem Biol. 2013;8(4):684–90. doi: 10.1021/cb300673e .
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献